Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis (Q34247727)

31 July 2017

0 references

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis (English)

1 reference

31 July 2017

0 references

1 reference

2

Janet Wittes

1 reference

31 July 2017

15

Emily Y Chew

1 reference

31 July 2017

6

Monica M Bertagnolli

1 reference

31 July 2017

Scott D Solomon

1

1 reference

31 July 2017

Peter V Finn

3

1 reference

31 July 2017

Robert Fowler

4

1 reference

31 July 2017

Jaye Viner

5

1 reference

31 July 2017

Nadir Arber

7

1 reference

31 July 2017

Bernard Levin

8

1 reference

31 July 2017

Curtis L Meinert

9

1 reference

31 July 2017

Barbara Martin

10

1 reference

31 July 2017

Joseph L Pater

11

1 reference

31 July 2017

Paul E Goss

12

1 reference

31 July 2017

Peter Lance

13

1 reference

31 July 2017

Stefanie Obara

14

1 reference

31 July 2017

Jonghyeon Kim

16

1 reference

31 July 2017

Gretchen Arndt

17

1 reference

31 July 2017

Ernest Hawk

18

1 reference

31 July 2017

Cross Trial Safety Assessment Group

19

1 reference

31 July 2017

language of work or name

English

0 references

publication date

31 March 2008

1 reference

31 July 2017

1 reference

31 July 2017

117

1 reference

31 July 2017

2104-2113

1 reference

31 July 2017

16

1 reference

Arterial stiffness as a risk factor for coronary atherosclerosis

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Celecoxib for the prevention of colorectal adenomatous polyps

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Celecoxib for the prevention of sporadic colorectal adenomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Cyclooxygenase inhibition and cardiovascular risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Coxibs and cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Prediction of sites of coronary atherosclerosis progression:In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Risk of cardiovascular events associated with selective COX-2 inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

The coxibs, selective inhibitors of cyclooxygenase-2.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Prediction of Coronary Heart Disease Using Risk Factor Categories

6 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

6 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Relationship between COX-2 specific inhibitors and hypertension

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965408

Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18378608

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1161/CIRCULATIONAHA.108.764530

1 reference

31 July 2017

1 reference

31 July 2017

1 reference